KFA3

General Information


DRACP ID  DRACP04408

Peptide Name   KFA3

Sequence  KFAKFAKKFAKFAKKFAKFAK

Sequence Length  21

UniProt ID  Not available

PubChem CID  Not available

Origin  Synthetic

Type  Synthetic peptide

Classification

  

Active ACP



Activity Information


Hemolytic Activity  Not available

Normal (non-cancerous) Cytotoxicity  Not available

Target  Not available

Affinity  Not available

Mechanism  Not available

Nature  Anticancer; Antibacterial



Structure Information


PDB ID  Not available

Predicted Structure  Not available

Helicity  Not available

Linear/Cyclic  Linear

Disulfide/Other Bond  Not available

N-terminal Modification  Free

C-terminal Modification  Amidation

Other Modification  None

Chiral  L



Physicochemical Information


Formula  C126H194N30O22

Absent amino acids  CDEGHILMNPQRSTVWY

Common amino acids  K

Mass  283803

Pl  11.7

Basic residues  9

Acidic residues  0

Hydrophobic residues  12

Net charge  9

Boman Index  -2121

Hydrophobicity  -35.71

Aliphatic Index  28.57

Half Life 
  Mammalian: >20 hour
  Yeast: >20 hour
  E.coli: ?

Extinction Coefficient cystines  0

Absorbance 280nm  0

Polar residues  0

Amino acid distribution



Literature Information


Literature 1

Pubmed ID 31953126

Title  Enhanced cell selectivity of hybrid peptides with potential antimicrobial activity and immunomodulatory effect

Doi Not available

Year  2020

Patent

Patent ID Not available

Patent Title  Not available

Other Iinformation  Not available

Other Published ID  Not available




DBAASP ID  19634

DRACP is developed by Dr.Zheng's team.